Diltiazem Hydrochloride Sustainedn Release Tablets IP 60 mg..........

Nov 28, 2023

Diltiazem Hydrochloride Sustainedn Release Tablets IP 60 mg

DILTITAB 60 is a medication used to treat various heart-related conditions, primarily hypertension (high blood pressure) and certain heart rhythm disorders. The sustained-release formulation allows for a gradual release of the medication over time, maintaining a more stable blood concentration. Here are key points about Diltiazem Hydrochloride Sustained Release 
Diltiazem belongs to the class of medications known as calcium DILTITAB 60 works by inhibiting the influx of calcium ions into cardiac and smooth muscle cells, leading to vasodilation (widening of blood vessels) and a reduction in heart rate.
Dosage:

DILTITAB 60  formulation is designed to be taken once or twice daily, depending on the specific product.
DILTITAB 60  tablets should be swallowed whole and not crushed or chewed, as this could interfere with the sustained
release mechanism.
DILTITAB 60  is used for the treatment of hypertension (high blood pressure) and certain types of angina (chest pain).
DILTITAB 60  is also prescribed for the management of certain heart rhythm disorders, such as atrial fibrillation or atrial flutter.
Monitoring:
Regular monitoring of blood pressure and heart rate is typically done to assess the effectiveness of the medication and make any necessary dosage adjustments.
Side Effects:
Common side effects may include dizziness, headache, flushing, and swelling in the ankles or feet.
Serious side effects are rare but can include heart rhythm disturbances or allergic reactions.
Contraindications:

DILTITAB 60  may be contraindicated in certain situations, such as severe bradycardia (slow heart rate) or heart block.
It's important to inform the healthcare provider about all medications, including over-the-counter drugs and supplements, being taken to avoid potential interactions.
DILTITAB 60  is advised in patients with certain conditions, such as congestive heart failure or liver impairment.
DILTITAB 60  may interact with other medications, so DILTITAB 60 important to inform the healthcare provider about all medications being taken.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:https://www.sterisonline.com/product/diltitab-60-133292
 

SHARE WITH